- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Erythromycin in the treatment efficacy of mycoplasma pneumonia in children
PAGE \* MERGEFORMAT 5
Erythromycin in the treatment efficacy of mycoplasma pneumonia in children
[Abstract] Objective erythromycin in the treatment of Mycoplasma pneumonia clinical efficacy. Methods We summarized 69 cases of Mycoplasma pneumoniae (MP infection in children, application of erythromycin 30 mg / (kg · d), half of the static point, half of the oral treatment clinical analysis. The results of 69 cases patients were cured. Conclusion pharmacokinetics and clinical efficacy of erythromycin treatment of mycoplasma pneumonia is a safe and effective antibiotics.
[Keywords:] mycoplasma pneumonia, erythromycin
Mycoplasma pneumonia is Mycoplasma (MP infection is the causative agent of infectious diseases in children is one, MP is not only invasion of the respiratory tract, can also lead to multiple organ damage. Currently the treatment of mycoplasma pneumonia, the clinical pediatrician has become more concerned about the issue, a large ring lactone antibiotics is a very effective treatment of mycoplasma pneumonia drugs. This application of 69 cases of erythromycin treatment in children with mycoplasma pneumonia, are summarized below.
1 Clinical data
1.1 General Information January 2006 ~ May 2008 I patient treated 69 cases of mycoplasma pneumonia in children, male 40 cases, female 29, age 1 to 7 years old.
1.2 Diagnostic criteria (1 respiratory symptoms and (or signs. (2X-ray showed different degrees of lung inflammation. (3MP-IgM positive. Are in line with Hu Yamei, etc. lt;lt;Practical Pediatricsgt;gt; Seventh Edition, diagnosis of mycoplasma pneumonia standard [1].
1.3 Treatment methods are routinely given cough, phlegm, asthma and other symptomatic comprehensive treatment. Erythromycin 30 mg / (kg · d) half of the static point, half of the orally 2 times a day, the morning of static points: glucose injection 250 ~ 500 ml plus 4% sodium bicarbonate injection 1 ~ 2 ml, plus racemic Anisodamine injection 1 ~ 2 mg. course of 7 to 14 days
您可能关注的文档
- Epichlorohydrin for tissue engineering heart valve 1,3 in matrix metalloproteinase expression in.doc
- Epidemiological Analysis of HIV infection among drug users.doc
- Ephedrine Extraction Process.doc
- Epidemic cerebrospinal meningitis case-fatality rate of Markov Prediction Model.doc
- Epidemiological investigation of 282 cases of childhood burns and preventive measures.doc
- Epidemiological features of 289 cases of measles and case analysis.doc
- Epidemiological investigation of senile hypertension pastoralists and intervention.doc
- Epidemic encephalitis IL-1 neuron-specific enolase and its clinical significance.doc
- Epidemiological characteristics of TB Prevention and Control Force.doc
- Epidemiological studies of senile dementia status.doc
- Erxiantongguan Decoction post-menopausal women with recurrent urinary tract infections.doc
- Erythromycin on rat model of chronic obstructive pulmonary disease airway inflammation.doc
- Erythromycin on peripheral blood mononuclear cells in asthmatic rats phosphorylation of JNK expression.doc
- Erythropoietin and cerebral ischemic injury.doc
- Erythropoietin on A25 ~ 35 cells induced by nerve injury in vitro.doc
- Erythropoietin on neonatal hypoxic ischemic encephalopathy in serum SOD NO levels.doc
- Erythropoietin on the retinal optic nerve protective effect of.doc
- Erythropoietin on hemodynamics in rats with myocardial infarction and infarct size of.doc
- Erythropoietin potential protective effects of progress.doc
- ESBLs producing bacteria in elderly patients with pulmonary infection and drug resistance survey.doc
文档评论(0)